Normal circulating serum amyloid P component concentration in systemic sclerosis

Arthritis and Rheumatism

Volumn 56, Issue 6, 2007, Pages 2013-2017

  Tennent, Glenys A ^a   Dziadzio, Magdalena ^a   Triantafillidou, Eva ^a   Davies, Phillip ^a   Gallimore, J Ruth ^a   Denton, Christopher P ^a   Pepys, Mark B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID P COMPONENT; C REACTIVE PROTEIN; SERUM AMYLOID A; SERUM AMYLOID P;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROIMMUNOASSAY; FEMALE; FIBROSIS; HUMAN; LONGITUDINAL STUDY; MALE; MEASUREMENT; NEPHELOMETRY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; BLOOD; CROSS-SECTIONAL STUDY; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ACUTE-PHASE PROTEINS; ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROSIS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SERUM AMYLOID P-COMPONENT; SEVERITY OF ILLNESS INDEX;

EID: 34447536609     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22694     Document Type: Article

References (17)

1. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003;171:5537-46.
2. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. Amyloid P component: a critical review. Amyloid: Int J Exp Clin Invest 1997;4:274-95.
3. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
4. Pepys MB, Dash AC, Markham RE, Thomas HC, Williams BD, Petrie A. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 1978;32:119-24.
5. Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, Hutchinson WL, et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A 1994;91:5602-6.
6. Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med 1997;3:855-9.
7. Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A 2000;97:14584-9.
8. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med 1999;5:694-7.
9. Gillmore JD, Hutchinson WL, Herbert J, Bybee A, Mitchell DA, Hasserjian RP, et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 2004;112:255-64.
10. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002;417:254-9.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
12. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
13. Nelson SR, Tennent GA, Sethi D, Gower PE, Ballardie FW, Amatayakul-Chantler S, et al. Serum amyloid P component in chronic renal failure and dialysis. Clin Chim Acta 1991;200:191-200.
14. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
15. Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GD, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934-8.
16. Wilkins J, Gallimore JR, Tennent GA, Hawkins PN, Limburg PC, van Rijswijk MH, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994;40:1284-90.
17. Hawkins PN, Wootton R, Pepys MB. Metabolic studies of radio-iodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest 1990;86:1862-9.